Researchers to apply smartphone apps to manage anxiety, depression in breast cancer patients news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Nicotine and menthol prohibitions will endanger lives Follow Us
Question of the Day
ANALYSIS/OPINION:
It would seem incomprehensible that the federal government would consider new laws that would disproportionally criminalize young African Americans. It would be even more incomprehensible that, as we are finally starting to recover from the COVID-19 pandemic, it would consider imposing new laws that would seriously damage public health and potentially cause millions of easily preventable deaths.
Yet the Biden FDA is considering exactly this, with proposals to force smokers to switch to more deadly types of tobacco, while, with no health rationale, criminalizing the smoking habits of primarily young African American males.
Immunotherapies. Vaccines. We’ve all had a crash course in these subjects during this year of the pandemic.
Now a Farmington startup is taking immunotherapies and vaccines in new directions in the battle against disease including COVID-19.
Bijan Almassian is president and CEO at CaroGen Corp. His small team five full-time employees and five part-timers occupies space in UConn Health’s Cell and Genome Building on Farmington Avenue. But much of the firm’s research is going on in laboratories spread across several universities.
CaroGen’s lead product is an immunotherapy that targets Hepatitis B, a viral disease that affects the liver and is spread through bodily fluids. While there are Hep B vaccines on the market, the one CaroGen is working on is for treating chronic Hepatitis B, a disease that afflicts 240 million people worldwide.
University startup efforts push forward as new capital comes available
Accelerate Blue Fund will focus on early-stage investing for university startups
Tech transfer efforts continue forward at state s three research institutions
University of Michigan
Kelly Sexton with the University of Michigan s technology transfer office speaks about the Accelerate Blue venture capital fund
A long-planned philanthropic venture capital fund sponsored by the University of Michigan is up and running, with the goal of bolstering early stage startups in Ann Arbor and around the state.
The Accelerate Blue Fund aims to be a $20 million fund targeted at early stage companies looking to spin out from the university. All returns the fund realizes would be reinvested.
Another drug mess at North Shore’s ‘secret staircase’? (opinion)
Today 8:00 AM
Empty pharmacy pill bottles found at bottom of North Shore s secret staircase. (Tom Wrobleski/Staten Island Advance)
Facebook Share
But it’s a troubled area as well.
I’m talking about the “secret staircase” on the North Shore that goes from Tompkins Circle down to Victory Boulevard.
It’s a link between one of the tonier parts of the North Shore and a grittier, more working class neighborhood below.
It’s also been a spot where in years past I’ve found hypodermic needles, heroin packaging and other evidence of drug use.